Device Trial Radar · NCT04821154
Persona Revision Knee System Outcomes
Last checked: Nov 19, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
380
Planned (sponsor's estimate)
Start
Jun 14, 2021
Primary completion
Dec 31, 2033
Study completion Dec 31, 2033
Sponsor
- Lead sponsor
- Zimmer BiometPublic (ZBH)
- Sponsor type
- Industry
- First posted
- Mar 29, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the performance, clinical benefits and safety of the Persona Revision Knee System in patients who have received primary or revision total knee arthroplasty (TKA) treatment. This will be done using a multicenter, single-arm, consecutive series, retrospective cohort study with prospective follow-up.
Conditions
- Arthroplasty Complications
- Infection
- Knee Disease
- Knee Osteoarthritis
Interventions
Persona Revision Knee SystemDevice
Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Knee Society Clinical Rating System objective knee score (KS-KS)Time frame: 2 years
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Advanced Orthopaedic Specialists
Fayetteville, Arkansas · Recruiting
Bowen Hefley Orthopedics
Little Rock, Arkansas · Recruiting
Community Foundation Medical Group
Fresno, California · Withdrawn
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.